Parabilis Soared Biggest Biotech: Is It Too Late to Buy?
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Explore the best credit cards with rotating bonus categories to maximize your rewards. Find out how to earn more with smart choices.
26,498 articlesA record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Investors now have dedicated ETFs to take sides on the Magnificent Seven debate, including concentrated exposure via ...
Crypto funds see bitcoin potentially near a bottom as inflows return and risk appetite rekindles, signaling a potenti...
A European health-care group chief executive argues that craving work-life balance huge is a signal to reexamine job ...
A federal judge in Illinois denied CoStar's bid to join the Zillow-MRED-Compass dispute as an amicus. The ruling may ...
SpaceX isn’t publicly traded, but investors still wonder about the idea of a rising SpaceX stock. This guide breaks d...
With rate hikes looming in the background, a classic dividend stalwart delivers resilient income for retirees. The st...
A single AI infrastructure stock delivered an eye-popping 4,800% gain in 12 months. Here’s what drove that rally, wha...
Australia seals its largest defense export to date with a $1.75 billion radar pact in Canada, expanding Arctic securi...
Ripple won a preliminary CASP license from Luxembourg under MiCA, a key step in its EU expansion. The license is not ...
Binance withdraws its Greece bid and says it has one week to secure an EU license. The company reiterates that binanc...
Three Buy-rated names are drawing fresh attention in June as Wall Street echoes a defensive, cash-flow bias. AutoZone...